1. Home
  2. QSR vs BIIB Comparison

QSR vs BIIB Comparison

Compare QSR & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSR
  • BIIB
  • Stock Information
  • Founded
  • QSR 1954
  • BIIB 1978
  • Country
  • QSR Canada
  • BIIB United States
  • Employees
  • QSR N/A
  • BIIB N/A
  • Industry
  • QSR
  • BIIB Biotechnology: Pharmaceutical Preparations
  • Sector
  • QSR
  • BIIB Health Care
  • Exchange
  • QSR Nasdaq
  • BIIB Nasdaq
  • Market Cap
  • QSR 22.8B
  • BIIB 25.1B
  • IPO Year
  • QSR 2006
  • BIIB 1991
  • Fundamental
  • Price
  • QSR $69.61
  • BIIB $160.63
  • Analyst Decision
  • QSR Buy
  • BIIB Buy
  • Analyst Count
  • QSR 24
  • BIIB 25
  • Target Price
  • QSR $82.11
  • BIIB $260.48
  • AVG Volume (30 Days)
  • QSR 1.6M
  • BIIB 1.7M
  • Earning Date
  • QSR 11-05-2024
  • BIIB 10-30-2024
  • Dividend Yield
  • QSR 3.33%
  • BIIB N/A
  • EPS Growth
  • QSR 37.96
  • BIIB 10.05
  • EPS
  • QSR 4.00
  • BIIB 11.06
  • Revenue
  • QSR $7,930,000,000.00
  • BIIB $9,607,500,000.00
  • Revenue This Year
  • QSR $20.89
  • BIIB N/A
  • Revenue Next Year
  • QSR $10.78
  • BIIB N/A
  • P/E Ratio
  • QSR $17.41
  • BIIB $14.52
  • Revenue Growth
  • QSR 15.08
  • BIIB N/A
  • 52 Week Low
  • QSR $65.87
  • BIIB $153.62
  • 52 Week High
  • QSR $83.29
  • BIIB $268.30
  • Technical
  • Relative Strength Index (RSI)
  • QSR 50.75
  • BIIB 33.97
  • Support Level
  • QSR $68.91
  • BIIB $156.09
  • Resistance Level
  • QSR $70.49
  • BIIB $160.63
  • Average True Range (ATR)
  • QSR 1.28
  • BIIB 3.99
  • MACD
  • QSR 0.21
  • BIIB 0.46
  • Stochastic Oscillator
  • QSR 77.02
  • BIIB 31.52

About QSR Restaurant Brands International Inc.

Restaurant Brands International is one of the largest restaurant companies in the world, with approximately $43 billion in 2023 systemwide sales across a footprint that spanned more than 31,000 restaurants and more than 100 countries. The firm generates revenue primarily from retail sales at its company-owned restaurants, royalty fees and lease income from franchised stores, and from its Tim Hortons supply chain operations. Formed in 2014 after 3G Capital's acquisition of Tim Hortons International, the RBI portfolio is split among Burger King (7,144 units), Tim Hortons (4,525 units), Popeyes Louisiana Kitchen (3,394 units), Firehouse Subs (1,265 units), and international franchise units of those banners (14,742) as of year-end 2023.

About BIIB Biogen Inc.

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

Share on Social Networks: